Inventor
ZHONGXU REN
Inventor
US
Overview
Patents· 5 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes36%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations36%
C07KPeptides14%
C07BGeneral methods of organic chemistry7%
C07DHeterocyclic compounds7%
PatentTitleYear
12,325,708Adenosine 2 receptor antagonists202512,214,045Multi-arm polymer conjugates of TLR agonist compounds and related immunotherapeutic treatment methods202512,054,553Immunotherapeutic tumor treatment method202412,030,940Immunotherapeutic tumor treatment method202411,744,898Multi-arm polymer conjugates of TLR agonist compounds and related immunotherapeutic treatment methods2023Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2023–2025Patents assigned to NEKTAR THERAPEUTICS (5)· patent assignee history
2023–2025Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| NEKTAR THERAPEUTICS | 5 | 2023–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 5 | 2023–2025 |